Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Open in API
Filings indexed 761 across all filing types
Latest filing 2012-02-22 Interim / Quarterly Rep…
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Karolinska Development AB (publ) - Bokslutskommuniké 2011
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-End Report) for Karolinska Development AB for the period January–December 2011. It contains comprehensive financial statements, including income statements, cash flow, and balance sheet data, as well as detailed management commentary on business performance, portfolio developments, and clinical trial milestones. Since it covers a full fiscal year and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report (IR) in the context of European financial reporting standards where year-end reports are treated as the final quarterly/interim reporting period. FY 2011
2012-02-22 Swedish
Karolinska Development AB (publ) - Year-End Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Year-End Report 2011' and contains substantive financial data, including revenue, profit/loss, earnings per share, and cash flow for the full year and the fourth quarter. Although the introductory paragraph mentions the publication of the report, the document itself provides the actual financial statements and management commentary, distinguishing it from a mere announcement (RPA). It fits the definition of an Interim/Quarterly Report (IR) as it covers a period shorter than a full fiscal year (or in this case, the year-end results which function as the final quarterly/annual reporting period). FY 2011
2012-02-22 English
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Year-end report January – December 2011' and contains comprehensive financial statements, including revenue, profit/loss, earnings per share, cash flow, and balance sheet data for the full year and the fourth quarter. It also includes management commentary, operational updates, and portfolio information. As it covers a period shorter than a full fiscal year (Q4) and provides the full-year financial results, it fits the definition of an Interim/Quarterly Report (IR). FY 2011
2012-02-22 English
Karolinska Development - Bokslutskommuniké 2011, inbjudan till telefonkonferens onsdagen den 22 februari
Earnings Release Classification · 1% confidence The document text is an announcement titled "Karolinska Development - Bokslutskommuniké 2011, inbjudan till telefonkonferens onsdagen den 22 februari" (Year-end report 2011, invitation to conference call Wednesday, February 22nd). It explicitly states that the 'bokslutskommunikén' (year-end report/earnings release) for 2011 will be published tomorrow and invites participants to a conference call regarding this release. Since the document itself is an announcement about the upcoming release of a financial report and includes details for the associated conference call, it fits the description of a Report Publication Announcement (RPA) or potentially an Earnings Release (ER) announcement, but given the focus on announcing the *publication* of the report and the conference call details, RPA is a strong candidate. However, since the core subject is the release of the annual/year-end financial results ('bokslutskommuniké'), and the document is short and serves to notify the market about the upcoming release and Q&A session, it is best classified as an announcement regarding the release of financial results. Given the options, 'ER' (Earnings Release) often covers the initial announcement of periodical results, and 'RPA' (Report Publication Announcement) covers the announcement of the report's release. Since this is announcing the release of the *year-end* results and an associated call, it functions as the initial market communication about those results. If the text contained the actual results, it would be ER. Since it only announces the release time and invites to a call, RPA is technically more accurate based on Rule 2, but ER is often used for the initial communication surrounding annual/quarterly results. Given the Swedish term 'Bokslutskommuniké' which is the formal release of annual results, and the invitation to a conference call, this is the primary communication event for those results. I will classify it as ER as it is the announcement of the key financial results communication, which is often bundled with the call invitation, but RPA is also plausible if strictly following the 'announcement of publication' rule. Given the context of financial reporting, ER is the most relevant category for the communication surrounding the release of annual results. FY 2011
2012-02-21 Swedish
Karolinska Development - Year-End Report, conference call Wednesday, February 22
Report Publication Announcement Classification · 1% confidence The document is very short (1674 characters) and explicitly announces the future publication of the 'Year-End Report for 2011' on a specific date (February 22) and time, followed by an announcement of a conference call. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report 'will be published' classifies the document as a Report Publication Announcement (RPA), not the full report itself (which would likely be a 10-K or IR).
2012-02-21 English
KDev Oncology AB investerar i GliGene AB
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing that KDev Oncology AB (a subsidiary of Karolinska Development AB) has made its first investment in a newly formed company, GliGene AB, through a directed new share issue (nyemission). This action involves fundraising, capital structure change (issuance of shares to a new investor), and strategic investment. This aligns best with the 'Capital/Financing Update' category, which covers company fundraising and capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific financing event.
2012-02-14 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.